It was proposed that metronomic chemotherapy is able to decline pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and, simultaneously, increase anti-angiogenic factors such as thrombospondin-1 (TSP-1), probably playing a critical role in maintaining and inducing angiogenic tumor dormancy (139). The gene discussed is VEGFA; the disease is neoplasm.